SCHEMBL18657306

SCHEMBL18657306

NCOCCN1CCN(Cc2ccccc2)CC1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 5/20 0.60
CCR3 P51677 1/20 0.58
MC4R P32245 1/20 0.56
HTR2A P28223 1/20 0.54
HTR7 P34969 1/20 0.54
KDM4E B2RXH2 3/20 0.52
ALDH1A1 P00352 3/20 0.52
TDP1 Q9NUW8 1/20 0.52
POLB P06746 3/20 0.51
RECQL P46063 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
KMT2A Q03164 2/20 0.50
DRD4 P21917 1/20 0.50
MEN1 O00255 1/20 0.50
USP2 O75604 1/20 0.50
LMNA P02545 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10860524 0.86 SIGMAR1 (0.64) SIGMAR1CCR3MC4RHTR2AHTR7
SCHEMBL13460805 0.82 SMN1; SMN2 (0.58) SIGMAR1CCR3MC4RHTR2AHTR7
Hydrochloric Acid SCHEMBL11384744 0.82 CCR3 (0.61) SIGMAR1CCR3MC4RHTR2AHTR7
SCHEMBL544347 0.81 SIGMAR1 (0.74) SIGMAR1CCR3MC4R
SCHEMBL249489 0.80 SIGMAR1 (0.72) SIGMAR1CCR3MC4RPOLBKMT2A
SCHEMBL7608951 0.80 ALDH1A1 (0.56) SIGMAR1CCR3HTR2AHTR7KDM4E
SCHEMBL6657455 0.80 CCR3 (0.85) SIGMAR1CCR3MC4RPOLBDRD4
SCHEMBL6659913 0.80 CCR3 (0.79) SIGMAR1CCR3MC4RKDM4EALDH1A1
SCHEMBL6659339 0.80 SIGMAR1 (0.86) SIGMAR1CCR3MC4RPOLBKMT2A
SCHEMBL7604178 0.80 HRH1 (0.60) SIGMAR1CCR3MC4RHTR2AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2393794-B1 DESIGN, SYNTHESIS AND EVALUATION OF PROCASPASE ACTIVATING COMPOUNDS AS PERSONALIZED ANTI-CANCER DRUGS UNIV ILLINOIS (US) 2017-03-22 EP disclosed